Soligenix News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.12.20	Soligenix: Phase 3 Trial Of SGX942 Fails To Achieve Statistically Significant Benefit (RTTNews)
29.07.20	Pre-market Movers In Healthcare Sector: SNOA, ACHV, TMDI, IMRN… (RTTNews)
16.04.20	Stock Alert: Soligenix Stock Up 45% In Pre Market (RTTNews)
16.04.20	Soligenix Executes License Deal With BSX On Potential Covid-19 Vaccine; Stock Up (RTTNews)
23.03.20	Stock Alert: Soligenix Shares Surge 45% In Pre-Market (RTTNews)
24.02.20	Soligenix (SNGX) Has Busy Calendar Ahead (RTTNews)
16.10.18	SNGX Flashes DMC Recommendation, LENS On Watch, IOVA Slumps (RTTNews)
10.10.18	TRVN Nearing D-Day, ABUS Skids On Study Delay, SNGX On Watch (RTTNews)
04.06.18	Soligenix Announces Poster at the 2018 American Society of Microbiology Microbe Conference in Atlanta, Georgia (PR Newswire)
11.05.18	Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results (PR Newswire)
07.05.18	Soligenix to Present at the NYC Oncology Investor Conference 2018 (PR Newswire)
02.05.18	Transformative Pharmaceutical Solutions (TPS), LLC to Co-Present with Liquidia Technologies at the 6th Annual Chief Medical Officer Summit (PR Newswire)
27.03.18	EKSO Leaps, FDA Nod For DRIO, CRVS Up 38% This Month, VTL To Report Data In Sep. (RTTNews)
22.03.18	Soligenix Receives Orphan Drug Designation from the European Commission for RiVax® for Prevention of Ricin Poisoning (PR Newswire)
15.03.18	Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results (PR Newswire)
13.03.18	Soligenix to Present at the 12th Annual International Partnering Conference Bio-Europe Spring (PR Newswire)
25.01.18	Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials (PR Newswire)
02.01.18	Soligenix Announces US Patent Issuance for Use of Dusquetide in Oral Mucositis (PR Newswire)
21.12.17	Soligenix Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule (PR Newswire)
07.12.17	Fannie Mae Leaders Named Among 'Most Powerful' List (PR Newswire)
06.12.17	Universal Health Realty Income Trust Announces Dividend Increase (PR Newswire)
30.11.17	Soligenix to Receive $417,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program (PR Newswire)
27.11.17	Soligenix Announces Presentation and Poster at the 2017 Chemical and Biological Defense Science and Technology Conference in Long Beach, CA (PR Newswire)
13.11.17	Soligenix to Present at the 2017 Biotech and Money Showcase Conference (PR Newswire)
09.11.17	Soligenix to Present Data on Dusquetide in Combating Antibiotic-Resistant Infections at the 2nd Annual Superbugs & Superdrugs USA Conference (PR Newswire)
06.11.17	Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results (PR Newswire)
31.10.17	Soligenix Announces Pricing of $5,115,000 Concurrent Registered Direct Offering and Private Placement of Common Stock Priced Above Market (PR Newswire)
24.10.17	Broad-Spectrum Innate Defense Regulator Platform Technology to be Presented at the Peptide Therapeutics Foundation Symposium (PR Newswire)
17.10.17	Soligenix to Present at the 3rd Annual Dawson James Small Cap Conference (PR Newswire)
05.10.17	Dusquetide Technology Platform to be Presented at the 2nd World Congress and Expo on Immunology (PR Newswire)
25.09.17	Soligenix Announces $700,000 Subaward Supporting Development Collaboration on Thermostabilization of an Ebola Vaccine Candidate (PR Newswire)
20.09.17	Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer (PR Newswire)
18.09.17	Soligenix Announces $1.5 Million NCI SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-Cell Lymphoma (PR Newswire)
11.09.17	Dusquetide as a Potential Solution to Antimicrobial Resistant Bacteria to be Presented at the 2017 World Anti-Microbial Resistance Congress (PR Newswire)
07.09.17	Soligenix to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York City (PR Newswire)
05.09.17	Soligenix to Present at the 8th Annual Investing for Cures Forum in New York City (PR Newswire)
18.08.17	Industry Veteran Eric Mesko Joins Mooney Lyons Advisor Team (PR Newswire)
14.08.17	Tech 2000, Inc. Has Been Chosen by Metro Ethernet Forum to Deliver MEF-CECP and TNF Training at MEF17 (PR Newswire)
14.08.17	Soligenix Receives $2.5M in Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine (PR Newswire)
11.08.17	Soligenix Announces Recent Accomplishments And Second Quarter 2017 Financial Results (PR Newswire)
01.08.17	Technical Reports on Biotech Equities -- BioDelivery Sciences, BioLine Rx, Benitec Biopharma, and Soligenix (PR Newswire)
27.07.17	Soligenix Initiates Pivotal Phase 3 Clinical Trial of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Head and Neck Cancer Patients (PR Newswire)
19.07.17	Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH... (RTTNews)
06.07.17	Dusquetide Technology Platform to be Presented at the 2017 Drug Discovery and Therapy World Congress (PR Newswire)
21.06.17	Soligenix Receives Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine (PR Newswire)
19.06.17	Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer... (PR Newswire)
09.06.17	Technical Insights on Biotech Stocks -- Soligenix, Sorrento Therapeutics, Alcobra, and Akebia Therapeutics (PR Newswire)
18.05.17	Soligenix Announces Publication Of Its Phase 2 Long-term Follow-up Results Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients (PR Newswire)
11.05.17	Soligenix Announces Recent Accomplishments And First Quarter 2017 Financial Results (PR Newswire)
04.05.17	Medifast, Inc. Announces First Quarter 2017 Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	511.80	3.46 %	K V
Logitech Intl	80.84	2.10 %	K V
UBS Group	29.99	2.08 %	K V
Sika	221.90	1.42 %	K V
Sonova Hldg	304.30	1.30 %	K V
Roche Hldg G	264.40	0.38 %	K V
Novartis	90.42	0.34 %	K V
Alcon	75.86	0.21 %	K V
CieFinRichemont	139.75	-0.32 %	K V
Nestle	73.56	-0.81 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Soligenix Inc Registered Shs (Old)

Aktien Top/Flop

Meistgelesene Nachrichten